{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:13:02Z","timestamp":1778634782541,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2023R1A2C3006991"],"award-info":[{"award-number":["2023R1A2C3006991"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04354-w","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:21:59Z","timestamp":1775089319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral vascular damage-dependent drug permeability and anticancer effect of nano drug carriers: significant anticancer enhancement of combination therapy"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4975-7336","authenticated-orcid":false,"given":"Dohyeon","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip Gangadhar","family":"Balwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Myong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"4354_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","volume":"63","author":"F Jun","year":"2011","unstructured":"Jun F, Hideaki N, Hiroshi M. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"4354_CR2","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.7150\/thno.37198","volume":"9","author":"J Park","year":"2019","unstructured":"Park J, Choi Y, Chang H, Um W, Ryu JH, Kwon IC. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment. Theranostics. 2019;9:8073\u201390.","journal-title":"Theranostics"},{"issue":"8","key":"4354_CR3","first-page":"771","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu J. The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J Pers Med 2021;11 (8):771.","journal-title":"The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application"},{"key":"4354_CR4","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1038\/s41467-024-52416-0","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Hu Y, Zhang X, Shi X, Parak WJ, Pich A. Transvascular transport of nanocarriers for tumor delivery. Nat Commun. 2024;15:8172.","journal-title":"Nat Commun"},{"key":"4354_CR5","doi-asserted-by":"publisher","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","volume":"11","author":"New Insights","year":"2017","unstructured":"New Insights. into Permeability as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics. ACS Nano. 2017;11:9567\u20139.","journal-title":"ACS Nano"},{"key":"4354_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/thno.7193","volume":"4","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 2013, 4:81\u20139.","journal-title":"Theranostics"},{"issue":"6","key":"4354_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J Pers Med 2021;11(6):571.","journal-title":"J Pers Med"},{"issue":"2","key":"4354_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/jpm11020124","volume":"11","author":"D Huang","year":"2021","unstructured":"Huang D, Sun L, Huang L, Chen Y. Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect. J Pers Med 2021;11(2):124.","journal-title":"J Pers Med"},{"key":"4354_CR9","doi-asserted-by":"publisher","first-page":"021919","DOI":"10.1103\/PhysRevE.84.021919","volume":"84","author":"LJ Liu","year":"2011","unstructured":"Liu LJ, Brown SL, Ewing JR, Schlesinger M. Phenomenological model of interstitial fluid pressure in a solid tumor. Phys Rev E Stat Nonlin Soft Matter Phys. 2011;84:021919.","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"key":"4354_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2217\/14796694.4.6.793","volume":"4","author":"SJ Lunt","year":"2008","unstructured":"Lunt SJ, Fyles A, Hill RP, Milosevic M. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol. 2008;4:793\u2013802.","journal-title":"Future Oncol"},{"key":"4354_CR11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3389\/fphar.2017.00952","volume":"8","author":"B Zhang","year":"2017","unstructured":"Zhang B, Hu Y, Pang Z. Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery. Front Pharmacol. 2017;8:952.","journal-title":"Front Pharmacol"},{"key":"4354_CR12","doi-asserted-by":"publisher","first-page":"eaay1344","DOI":"10.1126\/sciadv.aay1344","volume":"6","author":"CT Curley","year":"2020","unstructured":"Curley CT, Mead BP, Negron K, Kim N, Garrison WJ, Miller GW, Kingsmore KM, Thim EA, Song J, Munson JM, et al. Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection. Sci Adv. 2020;6:eaay1344.","journal-title":"Sci Adv"},{"key":"4354_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1475-2867-14-41","volume":"14","author":"G Kharaishvili","year":"2014","unstructured":"Kharaishvili G, Simkova D, Bouchalova K, Gachechiladze M, Narsia N, Bouchal J. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int. 2014;14:41.","journal-title":"Cancer Cell Int"},{"key":"4354_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2019","unstructured":"Henke E, Nandigama R, Erg\u00fcn S. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy. Front Mol Biosci. 2019;6:160.","journal-title":"Front Mol Biosci"},{"key":"4354_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discov. 2024;14:1375\u201388.","journal-title":"Cancer Discov"},{"key":"4354_CR16","doi-asserted-by":"publisher","first-page":"114480","DOI":"10.1016\/j.addr.2022.114480","volume":"189","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Li J, Xiang J, Shao S, Zhou Z, Tang J, Shen Y. Transcytosis-enabled active extravasation of tumor nanomedicine. Adv Drug Deliv Rev. 2022;189:114480.","journal-title":"Adv Drug Deliv Rev"},{"key":"4354_CR17","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.7150\/thno.38587","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu X, Jiang J, Meng H. Transcytosis - An effective targeting strategy that is complementary to EPR effect for pancreatic cancer nano drug delivery. Theranostics. 2019;9:8018\u201325.","journal-title":"Theranostics"},{"issue":"9","key":"4354_CR18","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/cancers13092103","volume":"13","author":"S Sabatasso","year":"2021","unstructured":"Sabatasso S, Fernandez-Palomo C, Hlushchuk R, Fazzari J, Tschanz S, Pellicioli P, Krisch M, Laissue JA, Djonov V. Transient and Efficient Vascular Permeability Window for Adjuvant Drug Delivery Triggered by Microbeam Radiation. Cancers (Basel) 2021;13(9):2103.","journal-title":"Cancers (Basel)"},{"key":"4354_CR19","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","volume":"55","author":"Y Choi","year":"2023","unstructured":"Choi Y, Jung K. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy. Exp Mol Med. 2023;55:2308\u201319.","journal-title":"Exp Mol Med"},{"key":"4354_CR20","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1021\/bi020137x","volume":"41","author":"JM Song","year":"2002","unstructured":"Song JM, Milligan JR, Sutherland BM. Bistranded oxidized purine damage clusters: induced in DNA by long-wavelength ultraviolet (290\u2013400 nm) radiation? Biochemistry. 2002;41:8683\u20138.","journal-title":"Biochemistry"},{"key":"4354_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2013.00211","volume":"3","author":"S Azzi","year":"2013","unstructured":"Azzi S, Hebda JK, Gavard J. Vascular permeability and drug delivery in cancers. Front Oncol. 2013;3:211.","journal-title":"Front Oncol"},{"key":"4354_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3389\/fonc.2019.01227","volume":"9","author":"G Mattheolabakis","year":"2019","unstructured":"Mattheolabakis G, Mikelis CM. Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg? Front Oncol. 2019;9:1227.","journal-title":"Front Oncol"},{"issue":"1","key":"4354_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/pharmaceutics15010200","volume":"15","author":"AM Ross","year":"2023","unstructured":"Ross AM, Cahalane RM, Walsh DR, Grabrucker AM, Marcar L, Mulvihill JJE. Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell Barrier. Pharmaceutics 2023;15(1):200.","journal-title":"Pharmaceutics"},{"key":"4354_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s43094-023-00569-y","volume":"9","author":"M Haripriyaa","year":"2023","unstructured":"Haripriyaa M, Suthindhiran K. Pharmacokinetics of nanoparticles: current knowledge, future directions and its implications in drug delivery. Future J Pharm Sci. 2023;9:113.","journal-title":"Future J Pharm Sci"},{"key":"4354_CR25","doi-asserted-by":"publisher","first-page":"eadr4762","DOI":"10.1126\/sciadv.adr4762","volume":"10","author":"S Koshrovski-Michael","year":"2024","unstructured":"Koshrovski-Michael S, Ajamil DR, Dey P, Kleiner R, Tevet S, Epshtein Y, Green Buzhor M, Khoury R, Pozzi S, Shenbach-Koltin G, et al. Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin\u2013expressing cancers. Sci Adv. 2024;10:eadr4762.","journal-title":"Sci Adv"},{"issue":"6","key":"4354_CR26","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.3390\/ijms25063457","volume":"25","author":"J Lee","year":"2024","unstructured":"Lee J, Han S, Thapa Magar TB, Gurung P, Lee J, Seong D, Park S, Kim YW, Jeon M, Kim J. Efficient Assessment of Tumor Vascular Shutdown by Photodynamic Therapy on Orthotopic Pancreatic Cancer Using High-Speed Wide-Field Waterproof Galvanometer Scanner Photoacoustic Microscopy. Int J Mol Sci 2024;25(6):3457.","journal-title":"Int J Mol Sci"},{"key":"4354_CR27","first-page":"4271","volume":"21","author":"B Krammer","year":"2001","unstructured":"Krammer B. Vascular effects of photodynamic therapy. Anticancer Res. 2001;21:4271\u20137.","journal-title":"Anticancer Res"},{"key":"4354_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov. 2006;5:835\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"4354_CR29","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","volume":"7","author":"SM Wilhelm","year":"2008","unstructured":"Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7:3129\u201340.","journal-title":"Mol Cancer Ther"},{"key":"4354_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"M Giorgio","year":"2004","unstructured":"Giorgio M, Pierantonio M, Emanuela S, Gaetano C, Luca G. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol Rev. 2004;56:185\u2013229.","journal-title":"Pharmacol Rev"},{"key":"4354_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","volume":"21","author":"CF Thorn","year":"2011","unstructured":"Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics. 2011;21:440\u20136.","journal-title":"Pharmacogenet Genomics"},{"key":"4354_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17:611\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4354_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376.","journal-title":"Nat Med"},{"key":"4354_CR34","doi-asserted-by":"publisher","first-page":"100561","DOI":"10.1016\/j.apmt.2020.100561","volume":"19","author":"S Annie Agnes Suganya","year":"2020","unstructured":"Annie Agnes Suganya S, Sera H, Baskaran P, Jeongmin L, Joon Myong S. Transparent tumor microenvironment: Are liposomal nanoparticles sufficient for drug delivery to hypoxic regions and clonogenic cells? Appl Mater Today. 2020;19:100561.","journal-title":"Appl Mater Today"},{"key":"4354_CR35","doi-asserted-by":"publisher","first-page":"102441","DOI":"10.1016\/j.nantod.2024.102441","volume":"58","author":"H Sera","year":"2024","unstructured":"Sera H, Sandip Gangadhar B, Annie Agnes Suganya S, Joon Myong S. Striking hypoxic cancer cell killing effect of a tumor-responsive nanodrug carrier in tumor microenvironment. Nano Today. 2024;58:102441.","journal-title":"Nano Today"},{"key":"4354_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7150\/thno.99981","volume":"15","author":"S Hong","year":"2025","unstructured":"Hong S, Kim J, Chung G, Lee D, Song JM. Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma. Theranostics. 2025;15:30\u201351.","journal-title":"Theranostics"},{"key":"4354_CR37","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.nano.2015.07.015","volume":"11","author":"S Triantafyllos","year":"2015","unstructured":"Triantafyllos S, Rakesh KJ. Design considerations for nanotherapeutics in oncology. Nanomed Nanotechnol Biol Med. 2015;11:1893\u2013907.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"4354_CR38","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"C-H Heldin","year":"2004","unstructured":"Heldin C-H, Rubin K, Pietras K, \u00d6stman A. High interstitial fluid pressure \u2014 an obstacle in cancer therapy. Nat Rev Cancer. 2004;4:806\u201313.","journal-title":"Nat Rev Cancer"},{"key":"4354_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7:653\u201364.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04354-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04354-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04354-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:34:59Z","timestamp":1778632499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04354-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4354"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04354-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All surgical and experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Seoul National University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"430"}}